Novartis enters into US$390 million settlement

Swiss drug maker Novartis has agreed to pay US state and federal authorities US$390 million to resolve allegations that the company paid kickbacks to speciality pharmacies. In return for kickbacks the pharmacies would recommend Novartis drugs to patients.